미래에셋 제약/바이오 김승민

📈 Analytical overview of Telegram channel 미래에셋 제약/바이오 김승민

Channel 미래에셋 제약/바이오 김승민 (@bioksm) in the Korean language segment is an active participant. Currently, the community unites 14 654 subscribers, ranking 8 344 in the Economy & Finance category and 340 in the Korea region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 14 654 subscribers.

According to the latest data from 05 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 154 over the last 30 days and by -2 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 33.59%. Within the first 24 hours after publication, content typically collects 27.35% reactions from the total number of subscribers.
• Post reach: On average, each post receives 4 918 views. Within the first day, a publication typically gains 4 004 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“한국/미국/중국 바이오 업종에 대한 발간 자료와 의견 공유.”

Thanks to the high frequency of updates (latest data received on 06 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Economy & Finance category.